Inactive Instrument
Auspex Pharmaceuticals Inc Share Price
Stocks
US05211J1025
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 22/04/15 | Auspex Pharmaceuticals : Teva Pharmaceutical's history of key acquisitions | RE |
| 22/04/15 | Auspex Pharmaceuticals : Teva's turnaround CEO sets sights on $40 billion mega-deal | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Brendan O'Grady
CEO | Chief Executive Officer | 59 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sep Sarshar
BRD | Director/Board Member | 59 | 31/08/2009 |
Rod Ferguson
BRD | Director/Board Member | 69 | 31/12/2012 |
Alex Zisson
BRD | Director/Board Member | 56 | 16/10/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.03% | -2.05% | +39.28% | +94.60% | 68.87B | ||
| +2.09% | +1.34% | +50.66% | +93.64% | 65.29B | ||
| +4.21% | +1.80% | -12.85% | +459.32% | 27.65B | ||
| +2.97% | +0.40% | +38.60% | +12.79% | 25.77B | ||
| +1.83% | -7.77% | +3.17% | -14.74% | 26.08B | ||
| +2.16% | +2.40% | +27.75% | -16.67% | 20.14B | ||
| -0.38% | -17.67% | +214.37% | +373.18% | 17.03B | ||
| +0.77% | -5.28% | -3.25% | +539.79% | 15.03B | ||
| +2.88% | +4.33% | +57.42% | +157.39% | 14.5B | ||
| Average | +1.95% | -3.07% | +46.13% | +188.81% | 31.15B | |
| Weighted average by Cap. | +1.93% | -2.35% | +41.83% | +148.70% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
















